No. of Recommendations: 1
My vague recollection of that Roche conference call stated they expected top line results in 2nd half 2014 and launch in 2015. Roche stated they would eventually try to update on site. I will post again after I listen to the call again.

Briefly mentioned in Q&A. It was said that site has an error with completion date of 2017. Roche said it would be corrected and certainly sooner than that. I probably got my timeline specifics from this link.

Short timelines - The phase III trial will start next month with progression-free survival as the primary endpoint. Enrollment should be very quick, given Roche's experience in the indication (Zelboraf was the 1st approved drug for BRAF-mutated melanoma) and the fact that melanoma patients are routinely screened for BRAF status and treated with Zelboraf. Top line results could be available in mid-2014, and Roche expects to submit the combination for approval in 2014.

Don't know where Ohad got his timeline info. Maybe an educated guess?
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.